P&O Compliance Professional
Updated: March 03, 2024 09:37 AM GMT
Full-time Job in Bagsvaerd, Capital Region of Denmark
Novo Nordisk
Bagsværd, DenmarkPeople & Organisation Compliance Professional
Are you excited about shaping a safe and compliant culture? And are you up for a challenge to start our Compliance journey from (near) scratch to a high-quality and structured area?
If so, step into the role of People & Organisation (P&O) Compliance Professional and drive impactful Quality, Compliance and Health & Safety results for the Global P&O organisation.
The position
As our P&O Compliance Professional, you will be the link to the Quality, Compliance and Health & Safety areas, working together on the global processes, with authority to make the needed decisions that ensure we are in compliance. Also, you will represent P&O in relevant foras, and you will ensure we stay ahead of new regulations.
Some of your responsibilities will be to:
• Map out, plan and coordinate quality and compliance related information to management and employees in P&O.
• Establish and maintain overview and communication with local training coordinators... More Detail
Similar Jobs
Companies Hiring in Bagsvaerd, Capital Region of Denmark
Novo Nordisk
Novozymes
Lagkagehuset
Salling Group
Novo Nordisk
Q8 Danmark A/S
U.S. Embassy, Copenhagen - Denmark
Lidl Danmark
Novonesis
JYSK
NORMAL A/S
Velux A/S
Novo Nordisk
University of Copenhagen
DXC Technology
Novonesis
ReSound
New Jobs Posted in Bagsvaerd, Capital Region of Denmark
Latest Jobs in Bagsvaerd, Capital Region of Denmark
-
Analog IC Senior Manager
ReSound -
Department Assistant Talent Pipeline - Greater Copenhagen
Novo Nordisk A/S -
Process Manager for Quality Processes
Novo Nordisk -
Reparatør, Maintenance, Bagsværd
Novonesis -
Subject Matter Expert High Voltage Systems
Novo Nordisk A/S -
Senior Project Manager
DXC Technology -
医药代表-北京-GLP-1
Novo Nordisk -
Data Analyst
Novo Nordisk -
Ungarbejder til Q8 Bagsværd, 10 timer
Q8 Danmark A/S -
Laborantpraktikant til Novonesis med start 1. februar 2025
Novonesis